NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
The Integrated Medical Model: Statistical Forecasting of Risks to Crew Health and Mission SuccessThe Integrated Medical Model (IMM) helps capture and use organizational knowledge across the space medicine, training, operations, engineering, and research domains. The IMM uses this domain knowledge in the context of a mission and crew profile to forecast crew health and mission success risks. The IMM is most helpful in comparing the risk of two or more mission profiles, not as a tool for predicting absolute risk. The process of building the IMM adheres to Probability Risk Assessment (PRA) techniques described in NASA Procedural Requirement (NPR) 8705.5, and uses current evidence-based information to establish a defensible position for making decisions that help ensure crew health and mission success. The IMM quantitatively describes the following input parameters: 1) medical conditions and likelihood, 2) mission duration, 3) vehicle environment, 4) crew attributes (e.g. age, sex), 5) crew activities (e.g. EVA's, Lunar excursions), 6) diagnosis and treatment protocols (e.g. medical equipment, consumables pharmaceuticals), and 7) Crew Medical Officer (CMO) training effectiveness. It is worth reiterating that the IMM uses the data sets above as inputs. Many other risk management efforts stop at determining only likelihood. The IMM is unique in that it models not only likelihood, but risk mitigations, as well as subsequent clinical outcomes based on those mitigations. Once the mathematical relationships among the above parameters are established, the IMM uses a Monte Carlo simulation technique (a random sampling of the inputs as described by their statistical distribution) to determine the probable outcomes. Because the IMM is a stochastic model (i.e. the input parameters are represented by various statistical distributions depending on the data type), when the mission is simulated 10-50,000 times with a given set of medical capabilities (risk mitigations), a prediction of the most probable outcomes can be generated. For each mission, the IMM tracks which conditions occurred and decrements the pharmaceuticals and supplies required to diagnose and treat these medical conditions. If supplies are depleted, then the medical condition goes untreated, and crew and mission risk increase. The IMM currently models approximately 30 medical conditions. By the end of FY2008, the IMM will be modeling over 100 medical conditions, approximately 60 of which have been recorded to have occurred during short and long space missions.
Document ID
20080010658
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Fitts, M. A.
(NASA Johnson Space Center Houston, TX, United States)
Kerstman, E.
(Texas Univ. Galveston, TX, United States)
Butler, D. J.
(Wyle Labs., Inc. Houston, TX, United States)
Walton, M. E.
(Wyle Labs., Inc. Houston, TX, United States)
Minard, C. G.
(Wyle Labs., Inc. Houston, TX, United States)
Saile, L. G.
(Wyle Labs., Inc. Houston, TX, United States)
Toy, S.
(Muniz Engineering, Inc. Houston, TX, United States)
Myers, J.
(NASA Glenn Research Center Cleveland, OH, United States)
Date Acquired
August 24, 2013
Publication Date
February 4, 2008
Subject Category
Aerospace Medicine
Meeting Information
Meeting: Human Research Program Investigators'' Workshop
Location: League City, TX
Country: United States
Start Date: February 4, 2008
End Date: February 6, 2008
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available